Wagner Wealth Management (South Carolina)’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20	Closed	-$1.27K	–	233
2022 Q4	$1.27K	Hold	20	–	–	﹤0.01%	218
2022 Q3	$1K	Hold	20	–	–	﹤0.01%	653
2022 Q2	$1K	Sell	20 -120	-86%	-$6.91K	﹤0.01%	671
2022 Q1	$8K	Buy	140 +30	+27%	+$1.83K	0.01%	186
2021 Q4	$8K	Hold	110	–	–	0.01%	519
2021 Q3	$8K	Sell	110 -135	-55%	-$10.3K	0.01%	496
2021 Q2	$19K	Buy	245 +195	+390%	+$14.5K	0.01%	395
2021 Q1	$4K	Hold	50	–	–	﹤0.01%	571
2020 Q4	$4K	Buy	+50	New	+$3.17K	﹤0.01%	199

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s PBE Position: Q1 2023 in Review

Wagner Wealth Management (South Carolina) sold out of Invesco Biotechnology & Genome ETF (PBE) in Q1 2023, closing a stake of 20 shares — an estimated $1.27K sold.

Wagner Wealth Management (South Carolina) first reported a position in PBE in Q4 2020 and held it in 9 quarters. The position peaked at $19K in Q2 2021. 101 funds tracked by Wall St. Rank hold PBE as of Q1 2023.

Wagner Wealth Management (South Carolina) reported no remaining Invesco Biotechnology & Genome ETF position as of Q1 2023 after selling out during the quarter.
Wagner Wealth Management (South Carolina) sold 20 Invesco Biotechnology & Genome ETF shares in Q1 2023, an estimated $1.27K.
Wagner Wealth Management (South Carolina) first reported a position in Invesco Biotechnology & Genome ETF in Q4 2020 and held it in 9 quarters.
Wagner Wealth Management (South Carolina)'s Invesco Biotechnology & Genome ETF position peaked at $19K in Q2 2021.
101 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2023.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q1 2023, filed 17 May 2023.